Indication
Ototoxic Hearing Loss
1 clinical trial
1 product
Clinical trial
Clinical Trial: Intratympanic Injection of N-acetylcysteine for Protection of Cisplatin-induced OtotoxicityStatus: Terminated, Estimated PCD: 2023-05-03
Product
N-acetyl cysteine